BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25544754)

  • 1. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
    Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C
    Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
    Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
    Cells; 2019 May; 8(5):. PubMed ID: 31109089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro.
    Harting T; Stubbendorff M; Willenbrock S; Wagner S; Schadzek P; Ngezahayo A; Murua Escobar HM; Nolte I
    Int J Oncol; 2016 Dec; 49(6):2341-2350. PubMed ID: 27748833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
    Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
    Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
    Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
    Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of two aspects of metabolism in breast cancer treatment.
    Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
    Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
    J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate.
    Yang J; Cao Q; Zhang H; Hao L; Zhou D; Gan Z; Li Z; Tong YX; Ji LN; Mao ZW
    Biomaterials; 2018 Sep; 176():94-105. PubMed ID: 29870900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic modulation of glioblastoma with dichloroacetate.
    Michelakis ED; Sutendra G; Dromparis P; Webster L; Haromy A; Niven E; Maguire C; Gammer TL; Mackey JR; Fulton D; Abdulkarim B; McMurtry MS; Petruk KC
    Sci Transl Med; 2010 May; 2(31):31ra34. PubMed ID: 20463368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
    Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichloroacetate induces apoptosis in endometrial cancer cells.
    Wong JY; Huggins GS; Debidda M; Munshi NC; De Vivo I
    Gynecol Oncol; 2008 Jun; 109(3):394-402. PubMed ID: 18423823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
    Pathak RK; Marrache S; Harn DA; Dhar S
    ACS Chem Biol; 2014 May; 9(5):1178-87. PubMed ID: 24617941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
    Nikravesh H; Khodayar MJ; Behmanesh B; Mahdavinia M; Teimoori A; Alboghobeish S; Zeidooni L
    BMC Cancer; 2021 Aug; 21(1):903. PubMed ID: 34364387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system.
    Zhang X; Dong Y; Zhao M; Ding L; Yang X; Jing Y; Song Y; Chen S; Hu Q; Ni Y
    Theranostics; 2020; 10(26):12044-12059. PubMed ID: 33204328
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
    Choi YW; Lim IK
    Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
    Stacpoole PW
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.